This finding is noteworthy, because previous research by Patil et al. indicated that the intratumoral plasma cells could accurately predict outcomes to PD-L1 blockade in non-small cell lung cancer, showing a strong correlation between plasma cell abundance and overall survival specific to PD-L1 blockade [42]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.